|
Market Closed -
NYSE
04:00:03 2026-10-30 pm EDT
|
5-day change | 1st Jan Change | ||
| 330.84 USD | +0.09% |
|
-0.05% | -2.05% |
| Oct. 21 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| Oct. 21 | Baird Adjusts Price Target on Cencora to $375 From $373 | MT |
| Market Cap | 63.13B 56.54B 52.01B 47.13B 88.09B 5,995B 89.74B 620B 249B 3,153B 237B 232B 9,944B | P/E 2026 * |
17.5x | P/E 2027 * | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 70.66B 63.29B 58.21B 52.75B 98.6B 6,710B 100B 694B 279B 3,529B 265B 260B 11,131B | EV / Sales 2026 * |
0.21x | EV / Sales 2027 * | 0.2x |
| Free-Float |
61.21% | Yield 2026 * |
0.72% | Yield 2027 * | 0.74% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
London S.E.
| 0HF3 | Delayed | |
|
Berne S.E.
| ABG | End-of-day quote | |
|
Tradegate
| ABG | Real-time | |
|
Xetra
| ABG | Delayed | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Boerse Muenchen
| ABG | Real-time | |
|
Wiener Boerse
| ABC | End-of-day quote | |
|
Borsa Italiana
| 1COR | End-of-day quote |
Last Transcript: Cencora, Inc.
| 1 day | +0.09% | ||
| 1 week | -0.05% | ||
| Current month | +10.19% | ||
| 1 month | +10.19% | ||
| 3 months | +5.96% | ||
| 6 months | +7.41% | ||
| Current year | -2.05% |
| 1 week | 320.06 |  | 340.19 |
| 1 month | 302.14 | | 345.46 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 184 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.7 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 2024-09-30 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 2026-06-28 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 2013-05-15 |
Robert Mauch
BRD | Director/Board Member | 59 | 2024-09-30 |
D. Mark Durcan
CHM | Chairman | 64 | 2025-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Other | Director | 275 | 0.0001% | ||
| 10/1/26 | Sell | Controller/Auditor | -986 | 0.0005% | ||
| 10/1/26 | Other | Director | 197 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | -0.05% | -3.04% | +78.44% | 63.13B | |
| +1.56% | +2.41% | -14.82% | +14.19% | 184B | |
| -6.38% | -4.98% | -20.90% | +11.15% | 112B | |
| -0.59% | +1.18% | +6.12% | +37.97% | 118B | |
| +3.42% | +1.71% | -42.32% | +9.52% | 94.58B | |
| -0.46% | +0.42% | +8.19% | +82.97% | 55.66B | |
| -0.23% | -0.52% | +10.31% | -21.19% | 53.9B | |
| -4.30% | -1.64% | -12.30% | +39.06% | 43.42B | |
| +0.58% | +2.00% | -1.07% | -6.43% | 34.68B | |
| +2.95% | +5.58% | +20.66% | -3.09% | 30.69B | |
| Average | -0.34% | +0.61% | -4.92% | +24.26% | 79B | |
| Weighted average by Cap. | -0.36% | +0.44% | -9.44% | +24.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 302B 278B 252B 470B 32,001B 479B 3,311B 1,329B 16,834B 1,265B 1,238B 53,087B | 352B 315B 290B 263B 491B 33,392B 500B 3,455B 1,387B 17,565B 1,320B 1,292B 55,395B |
| Net income | 3.58B 3.21B 2.95B 2.67B 5B 340B 5.09B 35.17B 14.12B 179B 13.44B 13.15B 564B | 2.84B 2.55B 2.34B 2.12B 3.97B 270B 4.04B 27.95B 11.22B 142B 10.68B 10.45B 448B |
| Net Debt | 7.53B 6.74B 6.2B 5.62B 10.51B 715B 10.7B 73.99B 29.7B 376B 28.26B 27.66B 1,186B | 5.95B 5.33B 4.9B 4.44B 8.3B 565B 8.45B 58.41B 23.45B 297B 22.32B 21.84B 937B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | $330.84 | +0.09% | 1,347,722 |
| 26-10-29 | $330.53 | +1.91% | 1,025,270 |
| 26-10-28 | $324.35 | -0.31% | 1,076,740 |
| 26-10-27 | $325.37 | -1.40% | 1,123,060 |
| 26-10-26 | $330.00 | -0.30% | 993,480 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
